This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Richard D. deShazo, MD

JAMA. 1997;278(22):2024-2025.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS EDITION of the Primer has been prepared during a time of great change in American medicine. The scientific progress that has facilitated the improved therapies for allergic, inflammatory, and immunodeficiency diseases detailed in these pages continues at a rapid pace—so rapid that practicing physicians and basic scientists struggle to keep up. At the same time, diminished federal support and the movement toward managed health care has limited the resources previously used by academic health centers to support research and education. Many fear that loss of this support will disable the conjoint process of medical education and biomedical research that has generated many of these improved therapies. How our national ambivalence over what is valued and supported in American medicine will ultimately resolve is unclear. It is clear that the allocation of support for research and education in our evolving health care system will affect not only future trends in . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?